Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Impact of Prophylactic Ephedrine on Fetal Heart Tracing and Uterine Tetanic Contraction After CSE 05/24/2023 INTERVENTIONAL unchanged 1,190.85 0 Preventing Postpartum Depression in Immigrant Latinas 05/24/2023 INTERVENTIONAL unchanged 1,190.85 0 Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer 05/24/2023 INTERVENTIONAL unchanged 1,190.85 0 Ovarian Tissue Cryopreservation for Fertility Preservation 05/25/2023 OBSERVATIONAL unchanged 1,189.85 0 Capecitabine and Cyclophosphamide (XC) as Maintenance Therapy for Advanced Breast Cancer 05/25/2023 INTERVENTIONAL unchanged 1,189.85 0 Postoperative Hypofractionated Intensity-modulated Radiotherapy Endometrial Cancer 05/25/2023 INTERVENTIONAL unchanged 1,189.85 0 Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab 05/26/2023 OBSERVATIONAL unchanged 1,188.85 0 Impact of Endocrine Therapy, Menstrual Cycle, PAM50, Ki67 on Treatment Decisions in HR+ and HER2- Breast Cancer 05/26/2023 OBSERVATIONAL unchanged 1,188.85 0 Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 05/30/2023 INTERVENTIONAL unchanged 1,184.85 0 Online Adaptive Radiotherapy Cervical Cancer With Reduced Margin for Cervical Cancer 05/30/2023 INTERVENTIONAL unchanged 1,184.85 0 Early Diagnosis and Intervention for Fetal Malposition in Active Labor and Its Impact on Mode of Delivery 05/31/2023 INTERVENTIONAL unchanged 1,183.85 0 The Cost-effectiveness of Hysterosalpingography Versus Hysterosalpingo-foam Sonography During Fertility Work-up 05/31/2023 INTERVENTIONAL unchanged 1,183.85 0 Reaching the Last 20% (the Pamoja Kwa Afya Study) 05/31/2023 INTERVENTIONAL unchanged 1,183.85 0 Epithesis Versus Prosthesis in Post-phalloplasty Transgender Patients. 06/01/2023 INTERVENTIONAL unchanged 1,182.85 0 EC-THP Versus TCbHP in HER2-positive Lymph Node Positive Early Breast Cancer 06/01/2023 INTERVENTIONAL unchanged 1,182.85 0 Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension 06/01/2023 INTERVENTIONAL unchanged 1,182.85 0 Hysterectomy by Transvaginal Natural Orifice Transluminal Endoscopic Surgery Versus or Laparoscopic Hysterectomy 06/01/2023 INTERVENTIONAL unchanged 1,182.85 0 Detection of Eating Disorders in Pregnant Women 06/02/2023 INTERVENTIONAL unchanged 1,181.85 0 An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib 06/05/2023 INTERVENTIONAL unchanged 1,178.85 0 Physical Activity and Cardiovascular Profile of Pre-conceptional Women At Risk for GHD 06/05/2023 INTERVENTIONAL unchanged 1,178.85 0 Pre-pectoral Breast Reconstruction With or Without Mesh 06/05/2023 INTERVENTIONAL unchanged 1,178.85 0 Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia 06/05/2023 INTERVENTIONAL unchanged 1,178.85 0 Neoadjuvant Concomitant Modulated Electro-hyperthermia in HER2-negative Breast Cancer 06/05/2023 INTERVENTIONAL unchanged 1,178.85 0 The UFIM (Ultraprocessed Foods In Breast Milk) Project 06/05/2023 OBSERVATIONAL unchanged 1,178.85 0 Resistance Exercise Training to Improve Bone and Articular Cartilage Health in Women 06/05/2023 INTERVENTIONAL unchanged 1,178.85 0 Vulvar Disease in Nigeria Observational Study 06/06/2023 OBSERVATIONAL unchanged 1,177.85 0 A Study of Chidamide Plus Endocrine in Maintenance Treatment of HR+/HER2- Breast Cancer After First-line Chemotherapy 06/06/2023 INTERVENTIONAL unchanged 1,177.85 0 Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01) 06/06/2023 INTERVENTIONAL unchanged 1,177.85 0 Short-course Trastuzumab, Pertuzumab with Taxanes in the Adjuvant Treatment of Early HER2-positive Breast Cancer 06/07/2023 INTERVENTIONAL unchanged 1,176.85 0 A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain 06/07/2023 INTERVENTIONAL unchanged 1,176.85 0 Physiological and Psychological Effects of Music Therapy in the Pregnant Woman and Fetus 06/08/2023 INTERVENTIONAL unchanged 1,175.85 0 Prospective Cohort for Tumor Bed Boost Radiotherapy in HER2 Positive Breast Cancer 06/08/2023 OBSERVATIONAL unchanged 1,175.85 0 Effect of a Probiotic on the Urinary Tract Microbiota of Participants With Recurrent Urinary Tract Infection. 06/08/2023 INTERVENTIONAL unchanged 1,175.85 0 The Mother in Norway Study 06/08/2023 INTERVENTIONAL unchanged 1,175.85 0 Radiotherapy Dose Adaptation Based on Tumor Biology in Patients With cN2b-N3 Breast Cancer 06/09/2023 INTERVENTIONAL unchanged 1,174.85 0 Feasibility and Acceptability of a Novel Cognitive Behavioral Skills Mobile App for Pregnant and Postpartum Individuals 06/09/2023 INTERVENTIONAL unchanged 1,174.85 0 A Novel, Regulated Gene Therapy (NGN-401) Study for Females With Rett Syndrome 06/12/2023 INTERVENTIONAL unchanged 1,171.85 0 MIcronized PROgesterone in Frozen Embryo Transfer Cycles 06/12/2023 INTERVENTIONAL unchanged 1,171.85 0 Seroma of the Mammary Gland 06/12/2023 INTERVENTIONAL unchanged 1,171.85 0 Estradiol Plus Olaparib for Breast Cancer (PHOEBE) 06/13/2023 INTERVENTIONAL unchanged 1,170.85 0 Prehabilitation and RecOVERy From Surgery for Breast Cancer Study 06/13/2023 INTERVENTIONAL unchanged 1,170.85 0 Development of 'My Breastfeeding Guide' Mobile Nursing Application 06/13/2023 INTERVENTIONAL unchanged 1,170.85 0 TCb vs EC-T in High Risk ER+/HER2- Breast Cancer 06/13/2023 INTERVENTIONAL unchanged 1,170.85 0 The Impact of a Race-Based Stress Reduction Intervention 06/15/2023 INTERVENTIONAL unchanged 1,168.85 0 Uterine Preservation Via Lifestyle Transformation 06/15/2023 INTERVENTIONAL unchanged 1,168.85 0 Pembrolizumab Combination With Lenvatinib in Pts With Recurrent,Persistent,Metastatic or Locally Advanced Vulvar Cancer Not Amenable to Curative Surgery or Radiotherapy 06/15/2023 INTERVENTIONAL unchanged 1,168.85 0 PRISMA Maternal and Newborn Health Study 06/15/2023 OBSERVATIONAL unchanged 1,168.85 0 Primary Chemoradiation VS. Neoadjuvant Chemotherapy Followed By Surgery As Treatment Strategy For LAVC 06/15/2023 INTERVENTIONAL unchanged 1,168.85 0 Neuroimaging of Opioid Phase (OPAL) 06/15/2023 INTERVENTIONAL unchanged 1,168.85 0 Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M) 06/18/2023 OBSERVATIONAL unchanged 1,165.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology